Insights

Publication | Pharmaceutical Compliance Monitor

Recent Trends in Whistleblower Protection under Dodd–Frank

October 20, 2014

Edward Buthusiem and Gary Miller discuss how pharmaceutical and medical device manufacturers should stay up to date with Dodd–Frank Act and SEC and DOJ fraud investigations and enforcement actions.

Read the full article.

Professionals

Related Professionals

Edward J. Buthusiem

Managing Director

Washington, DC